J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
María José Casanova,María Chaparro,Valle García-Sánchez,Óscar Nantes,E Leo,M Rojas-Feria,Aranzazu Jauregui-Amezaga,Santiago García-López,José María Huguet,Federico Argüelles-Arias,M Aicart,Ignacio Marín-Jiménez,María Gómez-García,Fernando Muñoz,M Esteve,Luis Bujanda,Xavier Cortés,Joan Tosca,J R Pineda,Míriam Mañosa,Jordina Llaó,Jordi Guardiola,Isabel Pérez-Martínez,C Muñoz,Yago González-Lama,Joaquín Hinojosa,J M Vázquez,M. P. Martínez-Montiel,Gloria Esther Rodriguez,R. Pajares,M F García-Sepulcre,Álvaro Hernández-Martínez,J.L. Pérez-Calle,Belén Beltrán,David Busquets,Laura Ramos,Fernando Bermejo,Jesús Barrio,M. Barreiro-de Acosta,O Roncedo,Xavier Calvet,Daniel Hervías,Fernando Gomollón,Mercedes Domínguez-Antonaya,Guillermo Alcain,Beatriz Sicilia,Carmen Duenas,Alexandra Gutierrez,R Lorente-Poyatos,Manuel Domínguez,Sam Khorrami,Carlos Taxonera,A Rodríguez-Pérez,Ángel Ponferrada,M. Van Domselaar,M L Arias-Rivera,Olga Merino,E Castro,J M Marrero,María Dolores Martín-Arranz,B. Botella,Luis Fernández-Salazar,David Monfort,V. Opio,Antonio García-Herola,M Menacho,P Ramírez-de la Piscina,D Ceballos,Pedro Almela,M Navarro-Llavat,V Robles-Alonso,A B Vega-López,Irene Moraleja,M T Novella,Carlos Castaño-Milla,A Sánchez-Torres,José Manuel Benítez,Cristina Rodríguez,Luísa Castro,Elena Garrido,E. Domènech,Esther Garcia-Planella,Javier P. Gisbert +82 more
TL;DR: The incidence rate of inflammatory bowel disease relapse after anti-TNF discontinuation is relevant and some predictive factors of relapse afterAnti-tumor necrosis factor drugs withdrawal have been identified and treatment with the same anti- TNF drug was effective and safe.
Journal ArticleDOI
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
Yago González-Lama,Fernando Bermejo,Antonio López-Sanromán,Valle García-Sánchez,Maria Esteve,José Luis Cabriada,Adrian G. McNicholl,R. Pajares,Francesc Casellas,Olga Merino,Daniel Carpio,M.I. Vera,Carmen Muñoz,Mari M. Calvo,L.M. Benito,Luis Bujanda,F. J. García-Fernández,Elena Ricart,Daniel Ginard,M. Velasco,J.A. Carneros,Noemí Manceñido,Alicia Algaba,C. Froilan,Carlos Cara,J. Maté,L. Abreu,Javier P. Gisbert +27 more
TL;DR: Aliment Pharmacol Ther 2011; 34: 544–554.
Journal ArticleDOI
Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence
TL;DR: Most of the scientific evidence supports the utility of subtyping IM as a predictor of GC risk, and recognizing its usefulness by gastroenterologists should encourage pathologists to subtype IM.
Journal ArticleDOI
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)
TL;DR: The aim of this study is to systematically review the efficacy of the second-line rescue therapies after the failure of a first-line clarithromycin-containing regimen, and to link this information with the previous first- line treatment.
Journal ArticleDOI
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Ma Teresa Arroyo,Montse Forne,Carlos Martín de Argila,Faust Feu,Juan Arenas,Juan de la Vega,Vicente Garrigues,Francisco Mora,Manuel Castro,Luis Bujanda,Angel Cosme,Agustin Castiella,Javier P. Gisbert,Antonio Hervás,Angel Lanas +14 more
TL;DR: It is found that the frequency of H. pylori‐negative peptic ulcer without intake of nonsteroidal anti‐inflammatory drugs (NSAIDs) in a Mediterranean European country seems to be increasing in developed countries.